Skip to main content

Table 5 Results of Meta-analysis of hospitalization days

From: Clinical and economic outcomes of hospital pharmaceutical care: a systematic review and meta-analysis

Study

| SMD

[95% Conf. Interval]

% Weight

Shen (2011) [18]

| -1.600

−2.871

−0.329

60.15

Cies (2013) [21]

| -3.000

−6.131

0.131

9.92

Dager (2014)

| -2.700

−4.502

−0.898

29.93

I-V pooled WMD

| -2.068

−3.054

−1.082

100.00

  1. Heterogeneity chi-squared = 1.33 (d.f. = 2) p = 0.513.
  2. I-squared (variation in WMD attributable to heterogeneity) = 0.0%.
  3. Test of WMD = 0: z = 4.11 p = 0.000.
  4. The significance level of the combined effect quantity test: 0.05.
  5. The significance level of the heterogeneity test: 0.1.
  6. Heterogeneity test: p > 0.1, no heterogeneity was considered; p < 0.1, heterogeneity was considered.